130 related articles for article (PubMed ID: 33246477)
1. Coverage determinants of breast cancer screening in Flanders: an evaluation of the past decade.
Ding L; Jidkova S; Greuter MJW; Van Herck K; Goossens M; Martens P; de Bock GH; Van Hal G
Int J Equity Health; 2020 Nov; 19(1):212. PubMed ID: 33246477
[TBL] [Abstract][Full Text] [Related]
2. The Role of Socio-Demographic Factors in the Coverage of Breast Cancer Screening: Insights From a Quantile Regression Analysis.
Ding L; Jidkova S; Greuter MJW; Van Herck K; Goossens M; De Schutter H; Martens P; Van Hal G; de Bock GH
Front Public Health; 2021; 9():648278. PubMed ID: 33937176
[No Abstract] [Full Text] [Related]
3. Relationship between health-related determinants and adherence to breast and colorectal cancer screening: a population-based study in Flanders, Belgium.
Ferrari A; Tran TN; Hoeck S; Peeters M; Goossens M; Van Hal G
Eur J Public Health; 2024 Apr; 34(2):347-353. PubMed ID: 38006217
[TBL] [Abstract][Full Text] [Related]
4. [Study on the coverage of cervical and breast cancer screening among women aged 35-69 years and related impact of socioeconomic factors in China, 2013].
Bao HL; Wang LH; Wang LM; Fang LW; Zhang M; Zhao ZP; Cong S
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):208-212. PubMed ID: 29495207
[No Abstract] [Full Text] [Related]
5. The impact of regional screening policies on the diffusion of cancer screening participation in Belgium: time trends in educational inequalities in Flanders and Wallonia.
Willems B; Bracke P
BMC Health Serv Res; 2018 Dec; 18(1):943. PubMed ID: 30514273
[TBL] [Abstract][Full Text] [Related]
6. Trends in stage-specific breast cancer incidence in New South Wales, Australia: insights into the effects of 25 years of screening mammography.
Jacklyn G; McGeechan K; Irwig L; Houssami N; Morrell S; Bell K; Barratt A
Breast Cancer Res Treat; 2017 Dec; 166(3):843-854. PubMed ID: 28822001
[TBL] [Abstract][Full Text] [Related]
7. Mammography use and mode of detection among breast cancer patients in Estonia.
Innos K; Valvere V; Padrik P; Eelma E; Kütner R; Lehtsaar J; Tekkel M
Women Health; 2016; 56(2):129-40. PubMed ID: 26327255
[TBL] [Abstract][Full Text] [Related]
8. European transnational ecological deprivation index and participation in population-based breast cancer screening programmes in France.
Ouédraogo S; Dabakuyo-Yonli TS; Roussot A; Pornet C; Sarlin N; Lunaud P; Desmidt P; Quantin C; Chauvin F; Dancourt V; Arveux P
Prev Med; 2014 Jun; 63():103-8. PubMed ID: 24345603
[TBL] [Abstract][Full Text] [Related]
9. Overdiagnosis of invasive breast cancer in population-based breast cancer screening: A short- and long-term perspective.
Ding L; Poelhekken K; Greuter MJW; Truyen I; De Schutter H; Goossens M; Houssami N; Van Hal G; de Bock GH
Eur J Cancer; 2022 Sep; 173():1-9. PubMed ID: 35839596
[TBL] [Abstract][Full Text] [Related]
10. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
[TBL] [Abstract][Full Text] [Related]
11. Reduction in advanced breast cancer after introduction of a mammography screening program in Tyrol/Austria.
Oberaigner W; Geiger-Gritsch S; Edlinger M; Daniaux M; Knapp R; Hubalek M; Siebert U; Marth C; Buchberger W
Breast; 2017 Jun; 33():178-182. PubMed ID: 28419909
[TBL] [Abstract][Full Text] [Related]
12. Proportion of women with self-reported opportunistic mammography before organized screening.
Heikkinen S; Miettinen J; Koskenvuo M; Huovinen R; Pitkäniemi J; Sarkeala T; Malila N
Acta Oncol; 2016 Jul; 55(7):865-9. PubMed ID: 27144814
[TBL] [Abstract][Full Text] [Related]
13. [Tailored Breast Screening Trial (TBST)].
Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
[TBL] [Abstract][Full Text] [Related]
14. [Early effects of attendance to the Friuli Venezia Giulia (Northern Italy) mammography screening programme on the incidence of advanced-stage breast cancer: a cohort study].
Giudici F; Bortul M; Clagnan E; Del Zotto S; Franzo A; Giordano L; Gobbato M; Puliti D; Serraino D; Zucchetto A; Zanier L; Zanconati F; Bucchi L
Epidemiol Prev; 2020; 44(2-3):145-153. PubMed ID: 32631014
[TBL] [Abstract][Full Text] [Related]
15. Low Coverage and Disparities of Breast and Cervical Cancer Screening in Thai Women: Analysis of National Representative Household Surveys.
Mukem S; Meng Q; Sriplung H; Tangcharoensathien V
Asian Pac J Cancer Prev; 2015; 16(18):8541-51. PubMed ID: 26745114
[TBL] [Abstract][Full Text] [Related]
16. Predictors and Trend in Attendance for Breast Cancer Screening in Lithuania, 2006-2014.
Kriaucioniene V; Petkeviciene J
Int J Environ Res Public Health; 2019 Nov; 16(22):. PubMed ID: 31744058
[TBL] [Abstract][Full Text] [Related]
17. Breast Cancer Mortality After Implementation of Organized Population-Based Breast Cancer Screening in Norway.
Sebuødegård S; Botteri E; Hofvind S
J Natl Cancer Inst; 2020 Aug; 112(8):839-846. PubMed ID: 31848605
[TBL] [Abstract][Full Text] [Related]
18. Effect of implementing digital breast tomosynthesis (DBT) instead of mammography on population screening outcomes including interval cancer rates: Results of the Trento DBT pilot evaluation.
Bernardi D; Gentilini MA; De Nisi M; Pellegrini M; Fantò C; Valentini M; Sabatino V; Luparia A; Houssami N
Breast; 2020 Apr; 50():135-140. PubMed ID: 31607526
[TBL] [Abstract][Full Text] [Related]
19. Flemish breast cancer screening programme: 15 years of key performance indicators (2002-2016).
Goossens M; De Brabander I; De Grève J; Van Ongeval C; Martens P; Van Limbergen E; Kellen E
BMC Cancer; 2019 Oct; 19(1):1012. PubMed ID: 31660890
[TBL] [Abstract][Full Text] [Related]
20. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
